litlas
Log inCreate account

Carol Prives

Active 1977–2025

133
Papers
41,260
Citations
101
h-index
132
i10-index

Citations

Citations per year for Carol Prives1971: 1 citations1977: 3 citations1978: 11 citations1979: 19 citations1980: 6 citations1981: 4 citations1982: 2 citations1983: 10 citations1984: 11 citations1985: 7 citations1986: 15 citations1987: 15 citations1988: 13 citations1989: 14 citations1990: 41 citations1991: 69 citations1992: 162 citations1993: 218 citations1994: 165 citations1995: 237 citations1996: 216 citations1997: 245 citations1998: 311 citations1999: 754 citations2000: 696 citations2001: 794 citations2002: 651 citations2003: 498 citations2004: 510 citations2005: 390 citations2006: 488 citations2007: 336 citations2008: 310 citations2009: 370 citations2010: 391 citations2011: 334 citations2012: 361 citations2013: 376 citations2014: 439 citations2015: 297 citations2016: 349 citations2017: 275 citations2018: 270 citations2019: 832 citations2020: 862 citations2021: 840 citations2022: 664 citations2023: 519 citations2024: 686 citations2025: 350 citations2026: 16 citations1972–1976: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,205 citing papers, 36.4% of this breakdownChina: 1,551 citing papers, 10.9% of this breakdownUnited Kingdom: 967 citing papers, 6.8% of this breakdownGermany: 719 citing papers, 5% of this breakdownFrance: 542 citing papers, 3.8% of this breakdownJapan: 530 citing papers, 3.7% of this breakdownItaly: 511 citing papers, 3.6% of this breakdownCanada: 455 citing papers, 3.2% of this breakdownIsrael: 273 citing papers, 1.9% of this breakdownSpain: 272 citing papers, 1.9% of this breakdownAustralia: 253 citing papers, 1.8% of this breakdownIndia: 247 citing papers, 1.7% of this breakdown
0%36.4%Other 19.3%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology47.7%
  • Medicine46.7%
  • Immunology and Microbiology2.1%
  • Agricultural and Biological Sciences0.9%
  • Neuroscience0.7%
  • Chemistry0.3%
  • Other1.6%

Topics

  • Cancer-related Molecular Pathways14.3%
  • Epigenetics and DNA Methylation5.5%
  • RNA modifications and cancer4.8%
  • DNA Repair Mechanisms4.3%
  • Ubiquitin and proteasome pathways3.8%
  • Cancer Research and Treatments3.2%
  • Other64.1%

Coauthors

All papers

Open in search
  1. Blinded by the Light: The Growing Complexity of p53

    Authors: Karen H. Vousden, Carol Prives - Cell 2009 cited by 3,173

  2. GLS2 Is a Tumor Suppressor and a Regulator of Ferroptosis in Hepatocellular Carcinoma

    Authors: Sawako Suzuki, Divya Venkatesh, Hiroaki Kanda, Akitoshi Nakayama, Hiroyuki Hosokawa, Eunyoung Lee, Takashi Miki, Brent R. Stockwell, Koutaro Yokote, Tomoaki Tanaka, Carol Prives - Cancer Research 2022 cited by 159

  3. MDM2 and MDMX promote ferroptosis by PPARα-mediated lipid remodeling

    Authors: Divya Venkatesh, Nicholas A. O'Brien, Fereshteh Zandkarimi, David Tong, Michael E. Stokes, Denise Dunn, Everett S. Kengmana, Allegra T. Aron, Alyssa M. Klein, J. Csuka, Sung‐Hwan Moon, Marcus Conrad, Christopher J. Chang, Donald C. Lo, Angelo D’Alessandro, Carol Prives, Brent R. Stockwell - Genes & Development 2020 cited by 284

  4. p53 Represses the Mevalonate Pathway to Mediate Tumor Suppression

    Authors: Sung‐Hwan Moon, Chun‐Hao Huang, Shauna L Houlihan, Kausik Regunath, William A. Freed-Pastor, John P. Morris, Darjus F. Tschaharganeh, Edward R. Kastenhuber, Anthony M. Barsotti, Rachel Culp‐Hill, Wen Xue, Yu-Jui Ho, Timour Baslan, Xiang Li, Allison Mayle, Elisa de Stanchina, Lars Zender, David Tong, Angelo D’Alessandro, Scott W. Lowe, Carol Prives - Cell 2018 cited by 463

  5. Mutant p53: one name, many proteins

    Authors: William A. Freed-Pastor, Carol Prives - Genes & Development 2012 cited by 1,279

  6. Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species

    Authors: Sawako Suzuki, Tomoaki Tanaka, Masha V. Poyurovsky, Hidekazu Nagano, Takafumi Mayama, Shuichi Ohkubo, Maria Lokshin, Hiroyuki Hosokawa, Toshinori Nakayama, Yutaka Suzuki, Sumio Sugano, Eiichi Sato, Toshitaka Nagao, Koutaro Yokote, Ichiro Tatsuno, Carol Prives - National Academy of Sciences, Proceedings of the National Academy of Sciences 2010 cited by 685

  7. Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway

    Authors: William A. Freed-Pastor, Hideaki Mizuno, Xi Zhao, Anita Langerød, Sung‐Hwan Moon, Ruth Rodríguez‐Barrueco, Anthony M. Barsotti, Agustin Chicas, Wencheng Li, Alla Polotskaia, Mina J. Bissell, Timothy F. Osborne, Bin Tian, Scott Lowe, José M. Silva, Anne‐Lise Børresen‐Dale, Arnold J. Levine, Jill Bargonetti, Carol Prives - Cell 2012 cited by 868

  8. The roles and regulation of MDM2 and MDMX: it is not just about p53

    Authors: Alyssa M. Klein, Rafaela Muniz de Queiroz, Divya Venkatesh, Carol Prives - Genes & Development 2021 cited by 137

  9. Relevance of the p53–MDM2 axis to aging

    Authors: Danyi Wu, Carol Prives - Cell Death and Differentiation 2017 cited by 212

  10. p53 Gain-of-Function Mutation Induces Metastasis via BRD4-Dependent CSF-1 Expression

    Authors: Gizem Efe, Karen J. Dunbar, Kensuke Sugiura, Katherine Cunningham, Saul Carcamo, Spyros Karaiskos, Qiaosi Tang, Ricardo Cruz‐Acuña, Lois Resnick‐Silverman, Jessica Peura, Chao Lü, Dan Hasson, Andres J. Klein–Szanto, Alison M. Taylor, James J. Manfredi, Carol Prives, Anil K. Rustgi - Cancer Discovery 2023 cited by 45

  11. DNA Damage-Induced Phosphorylation of p53 Alleviates Inhibition by MDM2

    Authors: Sheau-Yann Shieh, Masako Ikeda, Yoichi Taya, Carol Prives - Cell 1997 cited by 2,102

  12. Enhanced Phosphorylation of p53 by ATM in Response to DNA Damage

    Authors: Sharon Banin, Lilach Moyal, Sheau-Yann Shieh, Yoichi Taya, Carl W. Anderson, L. Chessa, Nechama I. Smorodinsky, Carol Prives, Yuval Reiss, Yosef Shiloh, Yael Ziv - Science 1998 cited by 1,800

  13. Regulation of p53 activity through lysine methylation

    Authors: Sergei Chuikov, Julia K. Kurash, J. Wilson, Bing Xiao, N. Justin, Gleb S. Ivanov, Kristine McKinney, Paul Tempst, Carol Prives, S.J. Gamblin, Nickolai A. Barlev, Danny Reinberg - Nature 2004 cited by 811

  14. p53 at the crossroads of tumor immunity

    Authors: Gizem Efe, Anil K. Rustgi, Carol Prives - Nature Cancer 2024 cited by 62

  15. The Roles of MDM2 and MDMX in Cancer

    Authors: Orit Karni-Schmidt, Maria Lokshin, Carol Prives - Annual Review of Pathology Mechanisms of Disease 2016 cited by 310

  16. Mutant p53 Drives Pancreatic Cancer Metastasis through Cell-Autonomous PDGF Receptor β Signaling

    Authors: Susann Weissmueller, Eusebio Manchado, Michael Saborowski, John P. Morris, Elvin Wagenblast, Carrie Davis, Sung‐Hwan Moon, Neil T. Pfister, Darjus F. Tschaharganeh, Thomas Kitzing, Daniela E. Aust, Elke Markert, Jianmin Wu, Sean M. Grimmond, Christian Pilarsky, Carol Prives, Andrew V. Biankin, Scott W. Lowe - Cell 2014 cited by 476

  17. p53: A tale of complexity and context

    Authors: Moshe Oren, Carol Prives - Cell 2024 cited by 64

  18. Transcriptional Regulation by Wild-Type and Cancer-Related Mutant Forms of p53

    Authors: Neil T. Pfister, Carol Prives - Cold Spring Harbor Perspectives in Medicine 2016 cited by 141

  19. p21 can be a barrier to ferroptosis independent of p53

    Authors: Divya Venkatesh, Brent R. Stockwell, Carol Prives - Aging 2020 cited by 55

  20. Gain-of-function mutant p53: history and speculation

    Authors: Jill Bargonetti, Carol Prives - Journal of Molecular Cell Biology 2019 cited by 89

  21. Transcriptional regulation by p53: one protein, many possibilities

    Authors: Oleg Laptenko, Carol Prives - Cell Death and Differentiation 2006 cited by 503

  22. Accurate and sensitive quantification of protein-DNA binding affinity

    Authors: Chaitanya Rastogi, H. Tomas Rube, Judith F. Kribelbauer, Justin Crocker, Ryan Loker, Gabriella Martini, Oleg Laptenko, William A. Freed-Pastor, Carol Prives, David L. Stern, Richard S. Mann, Harmen J. Bussemaker - National Academy of Sciences, Proceedings of the National Academy of Sciences 2018 cited by 129

  23. The p53 C Terminus Controls Site-Specific DNA Binding and Promotes Structural Changes within the Central DNA Binding Domain

    Authors: Oleg Laptenko, Idit Shiff, William A. Freed-Pastor, Andrew Zupnick, Melissa Mattia, Ella Freulich, Inbal Shamir, Noam Kadouri, Tamar Kahan, James J. Manfredi, Itamar Simon, Carol Prives - Molecular Cell 2015 cited by 120

  24. Mutual protection of ribosomal proteins L5 and L11 from degradation is essential for p53 activation upon ribosomal biogenesis stress

    Authors: Slađana Bursać, Maja Cokarić Brdovčak, Martin Pfannkuchen, Ines Oršolić, Lior Golomb, Yan Zhu, Chen Katz, Lilyn Daftuar, Kristina Grabušić, Iva Vukelić, Vedrana Filić, Moshe Oren, Carol Prives, Siniša Volarević - National Academy of Sciences, Proceedings of the National Academy of Sciences 2012 cited by 221